Poltreg Competitors and Similar CompaniesClear all

Poltreg's competitors and similar companies include Fractyl Health, BioGenCell, glyscend and Carmot Therapeutics.
Poltreg
Poltreg
Poltreg is a company that provides therapy for the treatment of type 1 diabetes.
Fractyl Health
Fractyl Health
Fractyl Health (formerly known as Fractyl Laboratories) is a metabolic therapeutics company that develops therapies for treating type 2 diabetes (T2D) and obesity.
BioGenCell
BioGenCell
BioGenCell is a company developing a technology platform to creare treatment for blood vessel diseases typical of diabetes complication, smoking and arthrosclerosis.
glyscend
glyscend
glyscend is a company that develops a method of treating metabolic diseases.
Carmot Therapeutics
Carmot Therapeutics
Carmot Therapeutics is a clinical-stage biotechnology company focused on the discovery of disease-modifying therapies in metabolic disease and cancer.
Founding Date
Founding Date
2015
Founding Date
2010
Founding Date
2008
Founding Date
2014
Founding Date
2008
Type
Type
Private
Type
Public
Type
Private
Type
Private
Type
Subsidiary
Tags
Locations
Locations
Gdańsk, PL HQ
Gdańsk, PL
Locations
Burlington, US HQ
Locations
HQ
Locations
Baltimore, US HQ
Lowell, US
Locations
Berkeley, US HQ
Employees
Employees
5
Employees
88
Employees
15
Employees
9
Employees
109% decrease

Financial

Net income
Net income
N/A
Net income
($141m) (FY, 2025)
Net income
N/A
Net income
N/A
Net income
($38.8m) (FY, 2022)

Funding

Latest funding round
Latest funding round
$ 55.5k (almost 10 years ago)
Latest funding round
N/A
Latest funding round
$ 16m (about 4 years ago)
Latest funding round
$ 20.5m (almost 6 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 55.5k
Total funding raised
$ 190.1m
Total funding raised
$ 16m
Total funding raised
$ 21m
Total funding raised
$ 74.8m
For sources of this data, please see the company profile

View Company Profiles

Fractyl Health
HQ
Burlington, US
Employees
88

Fractyl Health (formerly known as Fractyl Laboratories) is a metabolic therapeutics company that develops therapies for treating type 2 diabetes (T2D) and obesity.

View company
BioGenCell
HQ
Employees
15

BioGenCell is a company developing a technology platform to creare treatment for blood vessel diseases typical of diabetes complication, smoking and arthrosclerosis.

View company
glyscend
HQ
Baltimore, US
Employees
9

glyscend is a company that develops a method of treating metabolic diseases.

View company
Carmot Therapeutics
HQ
Berkeley, US

Carmot Therapeutics is a clinical-stage biotechnology company focused on the discovery of disease-modifying therapies in metabolic disease and cancer.

View company